CYCC Valuation
Cyclacel Pharmaceuticals Inc
$
0.222
- Overview
- Forecast
- Valuation
CYCC Relative Valuation
CYCC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CYCC is overvalued; if below, it's undervalued.
Historical Valuation
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-0.93
P/B
Median3y
0.83
Median5y
0.90
-15.18
FCF Yield
Median3y
-324.00
Median5y
-208.31
Competitors Valuation Multiple
The average P/S ratio for CYCC's competitors is 103.08, providing a benchmark for relative valuation. Cyclacel Pharmaceuticals Inc Corp (CYCC) exhibits a P/S ratio of 526.25, which is 410.55% above the industry average. Given its robust revenue growth of -37.50%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
Revenue Growth
Market Cap
People Also Watch
GRNT
Granite Ridge Resources Inc
4.750
USD
-8.48%
HTLD
Heartland Express Inc
8.630
USD
-1.37%
REAX
Real Brokerage Inc
4.270
USD
-4.26%
KRUS
Kura Sushi USA Inc
50.910
USD
-6.71%
FMBH
First Mid Bancshares Inc
31.140
USD
-5.32%
DMRC
Digimarc Corp
11.630
USD
-8.06%
BXC
Bluelinx Holdings Inc
71.010
USD
-4.40%
MRNO
Murano Global Investments Plc
9.500
USD
+9.20%
COGT
Cogent Biosciences Inc
4.020
USD
-9.87%
BFS
Saul Centers Inc
32.320
USD
-3.58%
FAQ
Is Cyclacel Pharmaceuticals Inc (CYCC) currently overvalued or undervalued?
Cyclacel Pharmaceuticals Inc (CYCC) is now in the Fair zone, suggesting that its current forward PS ratio of 526.25 is considered Fairly compared with the five-year average of 33.67. The fair price of Cyclacel Pharmaceuticals Inc (CYCC) is between to according to relative valuation methord.
What is Cyclacel Pharmaceuticals Inc (CYCC) fair value?
How does CYCC's valuation metrics compare to the industry average?
What is the current P/B ratio for Cyclacel Pharmaceuticals Inc (CYCC) as of Apr 11 2025?
What is the current FCF Yield for Cyclacel Pharmaceuticals Inc (CYCC) as of Apr 11 2025?
What is the current Forward P/E ratio for Cyclacel Pharmaceuticals Inc (CYCC) as of Apr 11 2025?